Accelerating approval of these next-gen formulations by ten to eleven months doesnt change the patent timeline, but it compresses the product cycle: a higher-dose Wegovy and an oral Foundayo reach physicians and patients sooner, generate revenue sooner, establish market position sooner, and create clinical inertia patient stabilization on a specific formulation that makes future price negotiation more difficult for any payer, including CMS
At Set Point Medical Weight Loss Clinic, our experienced medical providers will evaluate your current treatment, your health status, any side effects you may be experiencing, and your overall goals
I can barely see the fine white scar any longer
Individual skin response Some people respond faster to treatments, while others need slower, gentler protocols due to sensitivity or hormonal triggers
Analysis of data from randomised trials disproved that theory